| Dr Ismet Lukolic, MD | |
|
100 Rawlins Dr, Seaford, DE 19973-5881 | |
| (302) 990-3300 | |
| Not Available |
| Full Name | Dr Ismet Lukolic |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 100 Rawlins Dr, Seaford, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275777039 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | C1-0011687 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Nanticoke Memorial Hospital | Seaford, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tidalhealth Physician Network, Inc. | 7315901253 | 75 |
News Archive
Labopharm Inc. and Gruppo Angelini today announced they have entered into an agreement to establish a joint venture in the United States for the commercialization of OLEPTRO, a novel once-daily formulation of the antidepressant trazodone approved by the U.S. Food and Drug Administration on February 3, 2010.
Southridge LLC, an investment firm providing capital to publicly listed companies, is pleased to announce that its affiliated fund has closed a private equity agreement for up to $7.5 million in equity financing with PuraMed BioScience.
Every aging baby boomer listens for the footsteps of Alzheimer's, and for good reason: It's estimated that 10 million American boomers will develop the disease. The need to develop preventative strategies, ideally long before Alzheimer's destructive, clinical symptoms appear, is critical.
A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.
A new study provides some of the first links between relatively common mutations in the blood cells of elderly humans and atherosclerosis.
› Verified 7 days ago
| Entity Name | Tidalhealth Physician Network, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467534636 PECOS PAC ID: 7315901253 Enrollment ID: O20041119000090 |
News Archive
Labopharm Inc. and Gruppo Angelini today announced they have entered into an agreement to establish a joint venture in the United States for the commercialization of OLEPTRO, a novel once-daily formulation of the antidepressant trazodone approved by the U.S. Food and Drug Administration on February 3, 2010.
Southridge LLC, an investment firm providing capital to publicly listed companies, is pleased to announce that its affiliated fund has closed a private equity agreement for up to $7.5 million in equity financing with PuraMed BioScience.
Every aging baby boomer listens for the footsteps of Alzheimer's, and for good reason: It's estimated that 10 million American boomers will develop the disease. The need to develop preventative strategies, ideally long before Alzheimer's destructive, clinical symptoms appear, is critical.
A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.
A new study provides some of the first links between relatively common mutations in the blood cells of elderly humans and atherosclerosis.
› Verified 7 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1467546135 PECOS PAC ID: 1658364740 Enrollment ID: O20160516002240 |
News Archive
Labopharm Inc. and Gruppo Angelini today announced they have entered into an agreement to establish a joint venture in the United States for the commercialization of OLEPTRO, a novel once-daily formulation of the antidepressant trazodone approved by the U.S. Food and Drug Administration on February 3, 2010.
Southridge LLC, an investment firm providing capital to publicly listed companies, is pleased to announce that its affiliated fund has closed a private equity agreement for up to $7.5 million in equity financing with PuraMed BioScience.
Every aging baby boomer listens for the footsteps of Alzheimer's, and for good reason: It's estimated that 10 million American boomers will develop the disease. The need to develop preventative strategies, ideally long before Alzheimer's destructive, clinical symptoms appear, is critical.
A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.
A new study provides some of the first links between relatively common mutations in the blood cells of elderly humans and atherosclerosis.
› Verified 7 days ago
| Entity Name | Bayhealth Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1023006434 PECOS PAC ID: 1658364740 Enrollment ID: O20160527000094 |
News Archive
Labopharm Inc. and Gruppo Angelini today announced they have entered into an agreement to establish a joint venture in the United States for the commercialization of OLEPTRO, a novel once-daily formulation of the antidepressant trazodone approved by the U.S. Food and Drug Administration on February 3, 2010.
Southridge LLC, an investment firm providing capital to publicly listed companies, is pleased to announce that its affiliated fund has closed a private equity agreement for up to $7.5 million in equity financing with PuraMed BioScience.
Every aging baby boomer listens for the footsteps of Alzheimer's, and for good reason: It's estimated that 10 million American boomers will develop the disease. The need to develop preventative strategies, ideally long before Alzheimer's destructive, clinical symptoms appear, is critical.
A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.
A new study provides some of the first links between relatively common mutations in the blood cells of elderly humans and atherosclerosis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ismet Lukolic, MD 800 Poly Pl, Brooklyn, NY 11209-7104 Ph: (718) 836-6600 | Dr Ismet Lukolic, MD 100 Rawlins Dr, Seaford, DE 19973-5881 Ph: (302) 990-3300 |
News Archive
Labopharm Inc. and Gruppo Angelini today announced they have entered into an agreement to establish a joint venture in the United States for the commercialization of OLEPTRO, a novel once-daily formulation of the antidepressant trazodone approved by the U.S. Food and Drug Administration on February 3, 2010.
Southridge LLC, an investment firm providing capital to publicly listed companies, is pleased to announce that its affiliated fund has closed a private equity agreement for up to $7.5 million in equity financing with PuraMed BioScience.
Every aging baby boomer listens for the footsteps of Alzheimer's, and for good reason: It's estimated that 10 million American boomers will develop the disease. The need to develop preventative strategies, ideally long before Alzheimer's destructive, clinical symptoms appear, is critical.
A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013. The drug is called ORM-12741.
A new study provides some of the first links between relatively common mutations in the blood cells of elderly humans and atherosclerosis.
› Verified 7 days ago
Mir Mousavi, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 701 Middleford Rd, Seaford, DE 19973 Phone: 302-629-0260 Fax: 302-629-3418 | |
Deepa Bhanot, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 100 Rawlins Dr, Seaford, DE 19973 Phone: 302-990-3300 | |
Marie C Wolfgang, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 1 Cedar Ave, Seaford, DE 19973 Phone: 302-629-2366 Fax: 302-629-6570 | |
Linet Odhiambo Campbell, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 801 Middleford Rd, Seaford, DE 19973 Phone: 302-629-6611 | |
Mark John Granada, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 9109 Middleford Road, Seaford, DE 19973 Phone: 302-629-9483 Fax: 302-628-3977 | |
Dr. Ronald Concha Parra, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 701 Middleford Road, Seaford, DE 19973 Phone: 302-629-5193 Fax: 302-629-4273 |